Skip to main content
. 2023 Jun 14;14(1):62. doi: 10.1186/s12645-023-00213-7

Table 3.

The efficacy of the treatments in the B16F10 tumor-bearing mice

Groups TTEa TGD (%)b MSTc ILS (%)d
Buffer 23.5 ± 2.0 23.6
Naïve lip 26.7 ± 3.4 13.4 27.3 17.4
Lip-V1 33.1 ± 6.2 40.8 32.0 39.1
Lip-V2 26.9 ± 3.9 14.1 26.0 13.0
Lip-V3 27.4 ± 6.0 16.2 26.0 13.0

aTime to reach the end-point

bTumor growth delay (in comparison with the buffer group)

cMedian survival time

dIncrease life span